Table 1 Experimental setup overview.
From: Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition
Sample # | Name | Analysis | Treatment | FBS starved |
|---|---|---|---|---|
1 | DMSO control 7 days | Proteomics/Phosphoproteomics | DMSO | N |
2 | DMSO control 7 days | Proteomics/Phosphoproteomics | DMSO | N |
3 | Palbo 7 days | Proteomics/Phosphoproteomics | PD0332991 1 μM | N |
4 | Palbo 7 days | Proteomics/Phosphoproteomics | PD0332991 1 μM | N |
5 | Palbo 1 day | Proteomics/Phosphoproteomics | PD0332991 1 μM | N |
6 | Palbo 1 day | Proteomics/Phosphoproteomics | PD0332991 1 μM | N |
7 | Palbo 7 days | Secretome | PD0332991 1 μM | Y |
8 | Palbo 7 days | Secretome | PD0332991 1 μM | Y |
9 | Palbo 7 days | Secretome | PD0332991 1 μM | Y |
10 | DMSO control 7 days | Secretome | DMSO | Y |
11 | DMSO control 7 days | Secretome | DMSO | Y |
12 | DMSO control 7 days | Secretome | DMSO | Y |
